Anebulo Pharmaceuticals Inc
ANEB
Market Cap$50.57M
Close$
$0.12
92.9% downside
Current Fair Value
92.9% downsideOvervalued by 92.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $50.57 Million |
|---|---|
| Enterprise Value | $37.72 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.32 |
| Beta | -1.02 |
| Outstanding Shares | 25,822,258 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.14 |
|---|---|
| PEG | -448.66 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.69 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Anebulo Pharmaceuticals Inc
2 employees